This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furnari, F B
Right arrow Articles by Pagano, J S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furnari, F B
Right arrow Articles by Pagano, J S

 Previous Article  |  Next Article 

J Virol. 1994 March; 68(3): 1827-1836

RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

F B Furnari, V Zacny, E B Quinlivan, S Kenney and J S Pagano

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill 27599.

ABSTRACT

Epstein-Barr virus (EBV) is associated with the development of several types of human cancers and is an important cause of lymphomas in immunocompromised hosts. Expression of the EBV BZLF1 immediate-early gene product (Z) triggers disruption of latency in EBV-infected cells. Z is a member of the b-Zip family of proteins and binds to AP-1-like sites in early viral promoters. Here we show that a viral RNA related to Z, in which there is replacement of the transactivation domain of Z by fusion through alternate splicing with a portion of another EBV transactivator, BRLF1 (R), can repress Z function. This differentially spliced mRNA is predicted to express a novel chimeric protein which we call RAZ for R and Z. RAZ retains the dimerization and DNA-binding domains of Z but loses its transactivation domain. We show that in vitro the RAZ protein acts transdominantly to repress transactivation of early promoters by Z. Repression is produced by dimerization of RAZ with Z resulting in RAZ:Z heterodimers that can no longer bind to Z-binding sites despite retention of the DNA-binding domains in both proteins. Deletion of the R domain of RAZ restores the ability of the truncated RAZ homodimers and RAZ:Z heterodimers to bind to DNA. A biologic effect of RAZ was shown by cotransfection of latently infected Raji cells with Z and RAZ expression clones; RAZ diminished viral reactivation induced by Z, as indicated by amount of early replicative antigens (EA-D) detected. The RAZ protein presents a model for transcriptional control unique among the herpesvirus and distinct from analogous viral and cellular repressors. RAZ, by limiting the availability of Z protein, is likely to modulate EBV reactivation.

J Virol. 1994 March; 68(3): 1827-1836




This article has been cited by other articles:

  • Verma, D., Ling, C., Johannsen, E., Nagaraja, T., Swaminathan, S. (2009). Negative Autoregulation of Epstein-Barr Virus (EBV) Replicative Gene Expression by EBV SM Protein. J. Virol. 83: 8041-8050 [Abstract] [Full Text]  
  • Al Tabaa, Y., Tuaillon, E., Bollore, K., Foulongne, V., Petitjean, G., Seigneurin, J.-M., Duperray, C., Desgranges, C., Vendrell, J.-P. (2009). Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells. Blood 113: 604-611 [Abstract] [Full Text]  
  • Gray, K. S., Allen, R. D. III, Farrell, M. L., Forrest, J. C., Speck, S. H. (2009). Alternatively Initiated Gene 50/RTA Transcripts Expressed during Murine and Human Gammaherpesvirus Reactivation from Latency. J. Virol. 83: 314-328 [Abstract] [Full Text]  
  • Link, M. A., Schaffer, P. A. (2007). Herpes Simplex Virus Type 1 C-Terminal Variants of the Origin Binding Protein (OBP), OBPC-1 and OBPC-2, Cooperatively Regulate Viral DNA Levels In Vitro, and OBPC-2 Affects Mortality in Mice. J. Virol. 81: 10699-10711 [Abstract] [Full Text]  
  • Amon, W., Binne, U. K., Bryant, H., Jenkins, P. J., Karstegl, C. E., Farrell, P. J. (2004). Lytic Cycle Gene Regulation of Epstein-Barr Virus. J. Virol. 78: 13460-13469 [Abstract] [Full Text]  
  • Hong, G. K., Delecluse, H.-J., Gruffat, H., Morrison, T. E., Feng, W.-H., Sergeant, A., Kenney, S. C. (2004). The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1. J. Virol. 78: 4983-4992 [Abstract] [Full Text]  
  • Adamson, A. L., Kenney, S. (2001). Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia Bodies. J. Virol. 75: 2388-2399 [Abstract] [Full Text]  
  • Chang, P.-J., Liu, S.-T. (2001). Function of the Intercistronic Region of BRLF1-BZLF1 Bicistronic mRNA in Translating the Zta Protein of Epstein-Barr Virus. J. Virol. 75: 1142-1151 [Abstract] [Full Text]  
  • Dreyfus, D. H., Nagasawa, M., Kelleher, C. A., Gelfand, E. W. (2000). Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells. Blood 96: 625-634 [Abstract] [Full Text]  
  • Segouffin-Cariou, C., Farjot, G., Sergeant, A., Gruffat, H. (2000). Characterization of the Epstein-Barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1. J. Gen. Virol. 81: 1791-1799 [Abstract] [Full Text]  
  • Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J., Kenney, S. (2000). Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases. J. Virol. 74: 1224-1233 [Abstract] [Full Text]  
  • Lukac, D. M., Kirshner, J. R., Ganem, D. (1999). Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi's Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells. J. Virol. 73: 9348-9361 [Abstract] [Full Text]  
  • Adamson, A. L., Kenney, S. (1999). The Epstein-Barr Virus BZLF1 Protein Interacts Physically and Functionally with the Histone Acetylase CREB-Binding Protein. J. Virol. 73: 6551-6558 [Abstract] [Full Text]  
  • Edinger, J. W., Bonneville, M., Scotet, E., Houssaint, E., Schumacher, H. R., Posnett, D. N. (1999). EBV Gene Expression Not Altered in Rheumatoid Synovia Despite the Presence of EBV Antigen-Specific T Cell Clones. J. Immunol. 162: 3694-3701 [Abstract] [Full Text]  
  • Baumann, M., Mischak, H., Dammeier, S., Kolch, W., Gires, O., Pich, D., Zeidler, R., Delecluse, H.-J., Hammerschmidt, W. (1998). Activation of the Epstein-Barr Virus Transcription Factor BZLF1 by 12-O-Tetradecanoylphorbol-13-Acetate-Induced Phosphorylation. J. Virol. 72: 8105-8114 [Abstract] [Full Text]  
  • Chang, P.-J., Chang, Y.-S., Liu, S.-T. (1998). Role of Rta in the Translation of Bicistronic BZLF1 of Epstein-Barr Virus. J. Virol. 72: 5128-5136 [Abstract] [Full Text]  
  • Whitehouse, A., Cooper, M., Hall, K. T., Meredith, D. M. (1998). The Open Reading Frame (ORF) 50a Gene Product Regulates ORF 57 Gene Expression in Herpesvirus Saimiri. J. Virol. 72: 1967-1973 [Abstract] [Full Text]  
  • Prang, N. S., Hornef, M. W., Jager, M., Wagner, H. J., Wolf, H., Schwarzmann, F. M. (1997). Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State. Blood 89: 1665-1677 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»